Skip to main content
logo
BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
287.00
-2.65 (-0.91%)
Mar 17, 2026, 11:43 AM EDT - Market open

BeOne Medicines AG Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5,3433,8102,4591,4161,176
Revenue Growth (YoY)
40.23%54.96%73.65%20.37%280.83%
Cost of Revenue
668.54594.09379.92286.48164.91
Gross Profit
4,6743,2162,0791,1291,011
Selling, General & Admin
2,0811,8311,5081,279990.12
Depreciation & Amortization Expenses
----0.75
Research & Development
2,1461,9531,7791,6411,459
Total Operating Expenses
4,2273,7843,2872,9192,450
Operating Income
447.14-568.2-1,208-1,790-1,439
Interest Income
70.5169.6474.0152.48-15.76
Interest Expense
-58.23-21.81---
Other Non-Operating Income (Expense)
-42.55-12.64307.89-223.8515.9
Total Non-Operating Income (Expense)
-30.2835.2381.9-171.370.15
Pretax Income
416.85-533-825.84-1,961-1,439
Provision for Income Taxes
129.92111.7955.8742.78-25.23
Net Income
286.93-644.79-881.71-2,004-1,413
Net Income to Common
286.93-644.79-881.71-2,004-1,413
Shares Outstanding (Basic)
10910510410393
Shares Outstanding (Diluted)
11310510410393
Shares Change (YoY)
7.75%0.86%1.22%11.15%11.16%
EPS (Basic)
2.60-6.11-8.45-19.37-15.73
EPS (Diluted)
2.47-6.11-8.45-19.37-15.73
Free Cash Flow
941.74-633.29-1,719-1,822-1,562
Free Cash Flow Per Share
8.30-6.01-16.47-17.67-16.83
Gross Margin
87.49%84.41%84.55%79.77%85.98%
Operating Margin
8.37%-14.91%-49.12%-126.40%-122.31%
Profit Margin
5.37%-16.92%-35.86%-141.52%-120.15%
FCF Margin
17.63%-16.62%-69.93%-128.68%-132.76%
EBITDA
588.82-396.44-1,120-1,723-1,392
EBITDA Margin
11.02%-10.40%-45.55%-121.71%-118.36%
EBIT
447.14-568.2-1,208-1,790-1,439
EBIT Margin
8.37%-14.91%-49.12%-126.40%-122.31%
Effective Tax Rate
31.17%-20.97%-6.77%-2.18%1.75%
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q